Rezdiffra’s Approval: A Game-Changer for NASH Patients
The approval of Rezdiffra (resmetirom) marks a groundbreaking moment in the ongoing fight against Nonalcoholic Steatohepatitis (NASH), a chronic liver condition affecting millions worldwide. NASH, a progressive form of nonalcoholic fatty liver disease, is characterized by inflammation and damage to the liver, often leading to...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek